(Q26864102)

chronic renal insufficiency

main subject

1 reference

1 reference

Katherine Wesseling-Perry

series ordinal

1

object named as

Katherine Wesseling-Perry

1 reference

language of work or name

1 reference

April 2013

1 reference

1 reference

28

1 reference

issue

4

1 reference

page(s)

569-76

1 reference

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

The parathyroid is a target organ for FGF23 in rats

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Early skeletal and biochemical alterations in pediatric chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Value of the new bone classification system in pediatric renal osteodystrophy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Pathogenic role of Fgf23 in Dmp1-null mice.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Severe bone disease and low bone mineral density after juvenile renal failure

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

A novel mechanism for skeletal resistance in uremia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Sevelamer hydrochloride: an effective phosphate binder in dialyzed children

31 May 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

Long-term outcomes in pediatric renal transplant recipients who survive into adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-012-2324-4

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594120

Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease

28 November 2018

1 reference

12 December 2020

Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

1 reference

12 December 2020

PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease

1 reference

12 December 2020

25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity

1 reference

12 December 2020

Features of renal osteodystrophy in pediatric patients receiving regular peritoneal dialysis

1 reference

12 December 2020

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

12 December 2020

Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital

1 reference

12 December 2020

In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats

1 reference

12 December 2020

Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values

1 reference

12 December 2020

A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents

1 reference

12 December 2020

The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease

1 reference

12 December 2020

Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease

1 reference

12 December 2020

10.1007/S00467-012-2324-4

Identifiers

DOI

1 reference

Dimensions Publication ID

1045762643

0 references

1 reference

1 reference

PubMed publication ID

23064662

1 reference